Patient Risk Preference to be Used in Clinical Trial Design

A recent project collaboration between RTI Health Solutions, the Medical Device Innovation Consortium (MDIC) and the Michael J. Fox Foundation for Parkinson’s Research (MJFF) represents the first time patient preferences on benefits and risks have been used as an explicit means to set significance levels in a clinical trial design. Learn more here. (Source: RTI International, 10/18/16)

You might also be interested in:

PAI and BresMed Join Forces to Support Expanded Use of More… 07/22/2019
ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic… 02/20/2020
Biomarkers and Companion diagnostics: Payer Insights 09/26/2019
The Future of Personalised Medicine: The Role of Simulation… 01/25/2020
Real World Evidence (RWE) Solutions Market by Component,… 02/05/2020
The Growing Influence of the Institute of Clinical and… 11/21/2019
Leveraging Technology to Reduce Costs in Clinical Trials 06/30/2019